Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,173.9
9.1 (0.29%)

 

  • STI Straits Times Index
    3,173.9
    9.1 (0.29%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,598.3
    5.8 (0.36%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,331.0
    368.4 (1.48%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,572.4
    14.1 (0.40%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,068.6
    517.7 (1.81%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,633.3
    7.2 (0.11%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,492.6M
  • Value: 1,237.8M
  • Rise: 199
  • Fall: 127
  • Unch: 425

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.079+0.009
Rex Intl0.310+0.005
Genting Sing0.795+0.015
Ntegrator Intl0.009-
Geo Energy Res0.410-0.010
RH PetroGas0.205-
Sembcorp Marine0.080-
MarcoPolo Marine0.028-0.001
BlackGoldNatural0.019-
ThaiBev0.715+0.005

World Indices

World Indices
Name Last Change
Nasdaq 14,897.3 +73.9
HSI 25,331.0 +368.4
HSCEI 8,966.2 +117.0
Jakarta 6,633.3 +7.2
Nikkei 225 29,068.6 +517.7
SSE Comp 3,572.4 +14.1
Shanghai A 3,743.9 +14.8
Shanghai B 278.0 +0.5
KOSPI 3,015.1 +26.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MERCK & CO INC MERCK & CO.
Updated on 15 Oct 2021 (End of trading day)
Last (USD): 78.330 Change: - High: 79.060 Remarks: -
Change (%): - Low: 77.980
Open 78.200 Yesterday's Close 78.33
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 12,864,280 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 2.79177 Trailing EPS (USD) e 2.20078 NAV (USD) b 13.1526
PE a 28.057 Trailing PE f 35.592 Price / NAV b 5.9555
Dividend (USD) d 2.478878 Cash In Hand (USD) g 3.3875 Issued & Paid-up Shares c 2,531,370,000
Dividend Yield (%) d 3.165 Price / Cash In Hand g 23.123 Treasury Shares h 1,044,351,147
Market Cap (M) 198,282.212 Enterprise Value (M) 216,322.212
Piotroski F Score 6 Exchange Code MRK Par Value ( $ ) n.a.
52 Weeks Volatility (%) 21.11 Free Float (%) -
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 11 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Aug 2021.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MERCK & CO INC NYSE 198,282.212 28.057 35.592 5.9555 3.165
Industry Pharmaceuticals: Major NYSE 115,191.820 32.850 27.572 5.4139 2.082
Local Peer JOHNSON & JOHNSON NYSE 424,619.024 28.858 23.899 6.1026 2.467
Local Peer PFIZER INC NYSE 232,621.568 24.191 17.586 3.3212 3.662
Local Peer ELI LILLY AND COMPANY NYSE 227,551.488 36.739 37.484 35.3100 1.244
Local Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 202,860.219 24.982 22.555 3.7538 2.313
Local Peer ABBVIE INC NYSE 193,205.789 42.407 29.322 15.3715 4.422
Local Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 181,403.790 28.152 25.482 17.3508 1.314
Local Peer BRISTOL-MYERS SQUIBB CO NYSE 129,682.340 - - 3.5232 3.184
Local Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 98,144.089 13.313 16.547 4.6202 5.304
Local Peer TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS NYSE 44,619.591 12.586 11.049 0.9454 5.434
Local Peer BIOHAVEN PHARMACEUTICAL HLDG CO LTD NYSE 8,738.254 - - -19.2524 -
Local Peer ORGANON & CO NYSE 8,846.185 4.095 4.095 -4.5741 -
Local Peer EMERGENT BIOSOLUTIONS INC NYSE 2,722.088 8.922 9.098 1.7634 -
Other Local Peers ADC THERAPEUTICS SA (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), ZYMEWORKS INC (NYSE), LANNETT CO INC (NYSE)
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 186,577.819 58.379 49.477 11.9021 1.928
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 123,441.019 8.794 17.825 1.6460 2.738
Global Peer WUXI APPTEC CO LTD HKEx 488,672.596 147.237 105.525 11.0692 0.213
Global Peer ROYALTY PHARMA PLC NASDAQ 23,309.333 23.906 23.992 4.0653 0.500
Global Peer VIATRIS INC NASDAQ 16,277.043 - - 0.7675 -
Global Peer HANSOH PHARMACEUTICAL GROUP CO LTD HKEx 121,704.292 42.161 39.386 5.4097 0.375
Global Peer REPLIGEN CORP NASDAQ 14,674.514 244.876 146.844 9.1540 -
Global Peer INNOVENT BIOLOGICS INC HKEx 111,944.480 - - 7.8235 -
Global Peer CANSINO BIOLOGICS INC HKEx 72,142.320 - 91.601 8.5549 -
Global Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 9,083.592 - - 11.1415 -
Other Global Peers CUREVAC NV (NASDAQ), SINOPHARM GROUP CO. LTD. (HKEx), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), REMEGEN CO LTD (HKEx), ALLAKOS INC (NASDAQ), SHANGHAI PHARMACEUTICALS HOLDING CO (HKEx), HYGEIA HEALTHCARE HLDGS CO LTD (HKEx), HUTCHMED (CHINA) LIMITED (HKEx), HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), SHANGHAI JUNSHI BIOSCIENCES CO LTD (HKEx), AKESO INC (HKEx), CHINA MEDICAL SYSTEM HLDGS LTD (HKEx), GUANGZHOU BAIYUNSHAN PHARMACEUTICAL (HKEx), INNOCARE PHARMA LTD (HKEx), IMMUNITYBIO INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), CHINA RESOURCES PHARMACEUTICAL GR (HKEx), SPRINGWORKS THERAPEUTICS INC (NASDAQ), CARSGEN THERAPEUTICS HLDGS LTD (HKEx), CHINA GRAND PHARMACEUTICAL & HEALTH (HKEx), OPKO HEALTH INC (NASDAQ), SIMCERE PHARMACEUTICAL GRP LTD (HKEx), TURNING POINT THERAPEUTICS INC (NASDAQ), CHINA TRADITIONAL CHINESE MED HLDGS (HKEx), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ERASCA INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), SHANGHAI HENLIUS BIOTECH INC (HKEx), EVEREST MEDICINES LTD (HKEx), SHENZHEN HEPALINK PHARMACEUTICAL (HKEx), DICERNA PHARMACEUTICALS INC. (NASDAQ), OCUMENSION THERAPEUTICS (HKEx), SSY GROUP LIMITED (HKEx), CSTONE PHARMACEUTICALS (HKEx), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENERATION BIO CO (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), UNITED LABORATORIES INTL HLDGS LTD (HKEx), OLEMA PHARMACEUTICALS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), ABBISKO CAYMAN LTD (HKEx), Kimia Farma Tbk. (IDX), BEIJING TONG REN TANG CHINESE MEDIC (HKEx), FULCRUM THERAPEUTICS INC (NASDAQ), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), PROCAPS GROUP S A (NASDAQ), IMMUNOTECH BIOPHARM LTD (HKEx), CULLINAN ONCOLOGY INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), ICOSAVAX INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), KRONOS BIO INC (NASDAQ), SCICLONE PHARMACEUTICALS (HLDGS) LT (HKEx), ANTENGENE CORP LTD (HKEx), FORMA THERAPEUTICS HLDGS INC (NASDAQ), CK LIFE SCIENCES INTL HLDG (HKEx), SUTRO BIOPHARMA INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), TRANSCENTA HOLDING LTD (HKEx), PRAXIS PRECISION MEDICINES INC (NASDAQ), GH RESEARCH PLC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), ANNEXON INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), PETIQ INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), CHINA SHINEWAY PHARMACEUTICAL GR (HKEx), VERU INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), HUA MEDICINE (HKEx), SIGA TECHNOLOGIES INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), PHARVARIS NV (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), ZHAOKE OPHTHALMOLOGY LTD (HKEx), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), Soho Global Health Tbk. (IDX), APPLIED THERAPEUTICS INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), AC IMMUNE SA (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), IGBB (Bursa), EVOLUS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), CLENE INC (NASDAQ), PYXIS ONCOLOGY INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), 89BIO INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), ESSA PHARMA INC (NASDAQ), RACE ONCOLOGY LTD (ASX), VERRICA PHARMACEUTICALS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), DAWNRAYS PHARMACEUTICAL HLDGS (HKEx), TOT BIOPHARM INTL CO LTD (HKEx), EYEPOINT PHARMACEUTICALS INC (NASDAQ), CYBIN INC (NYSE American), FUSION PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), ATHENEX INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), NEXIMMUNE INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), XOMA CORP (NASDAQ), BSTEAD (Bursa), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), CHECKPOINT THERAPEUTICS INC (NASDAQ), DURECT CORP (NASDAQ), HARROW HEALTH INC (NASDAQ), FUSEN PHARMACEUTICAL CO LTD (HKEx), PHARMA (Bursa), VINCERX PHARMA INC (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ANNOVIS BIO INC (NYSE American), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), TRICIDA INC (NASDAQ), OBSEVA SA (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), IMMUNIC INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), MUSTANG BIO INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), ALZAMEND NEURO INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), IP (SET), SCPHARMACEUTICALS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), POLYPID LTD (NASDAQ), NOVAN INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), CHINA BIOTECH SERVICES HLDGS LTD (HKEx), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), EYENOVIA INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), IX Biopharma (SGX), ETON PHARMACEUTICALS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), ZHONGZHI PHARMACEUTICAL HLDGS LTD (HKEx), NOXOPHARM LTD (ASX), CYCLERION THERAPEUTICS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), Merck Tbk. (IDX), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), KOTRA (Bursa), CRESO PHARMA LTD (ASX), LYRA THERAPEUTICS INC (NASDAQ), IMARA INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), CHARMACY PHARMACEUTICAL CO LTD (HKEx), YUMANITY THERAPEUTICS INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), NEW RAY MEDICINE INTL HLDG LTD (HKEx), GALECTO INC (NASDAQ), PROPHASE LABS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), GRAYBUG VISION INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), Phapros Tbk. (IDX), ALLENA PHARMACEUTICALS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), PAK FAH YEOW INTERNATIONAL (HKEx), SANAI HEALTH INDUSTRY GP CO LTD (HKEx), Hyphens Pharma (SGX), NOVA (Bursa), EXOPHARM LTD (ASX), VYNE THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), NEW CENTURY HEALTHCARE HLDGS CO LTD (HKEx), INVION LTD (ASX), ABVC BIOPHARMA INC (NASDAQ), BIOHLDG (Bursa), BONE BIOLOGICS CORP (NASDAQ), VIRPAX PHARMA INC (NASDAQ), MODERN CHINESE MEDICINE GRP CO LTD (HKEx), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), SHENZHEN NEPTUNUS INTERLONG BIO-TEC (HKEx), UNIVERSE PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), RENOVORX INC (NASDAQ), WAI YUEN TONG MEDICINE HOLDINGS LTD (HKEx), BAUDAX BIO INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), SEQLL INC (NASDAQ), PURAPHARM CORPORATION LIMITED (HKEx), CNS PHARMACEUTICALS INC (NASDAQ), PHARMAXIS (ASX), VIRIOS THERAPEUTICS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), MEDLAB CLINICAL LIMITED (ASX), PASITHEA THERAPEUTICS CORP (NASDAQ), PALLA PHARMA LTD (ASX), ACER THERAPEUTICS INC (NASDAQ), AGEX THERAPEUTICS INC (NYSE American), JCT (SET), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), EXTRAWELL PHARMACEUTICAL HLDGS (HKEx), XORTX THERAPEUTICS INC (NASDAQ), SUNZEN (Bursa), HOTH THERAPEUTICS INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), TIMBER PHARMACEUTICALS INC (NYSE American), PANBELA THERAPEUTICS INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), ACRUX (ASX), IMMURON LIMITED (ASX), AVENUE THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), NANJING SINOLIFE UNITED COMPANY LTD (HKEx), TALI DIGITAL LIMITED (ASX), ISLAND PHARMACEUTICALS LTD (ASX), TELIGENT INC NEW (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), SUDA PHARMACEUTICALS LTD (ASX), PETROS PHARMACEUTICALS INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), PA SHUN INTERNATIONAL HOLDINGS LTD (HKEx), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --2.300
-2.85 %
10 Days --3.070
-3.77 %
20 Days -+6.650
+9.28 %
Medium Term Return 3 Months -+0.310
+0.40 %
6 Months -+4.347
+5.88 %
1 Year 16.250+2.093
+24.06 %
Long Term Return 2 Years 113.850-2.539
+137.64 %
3 Years 116.050+9.237
+181.33 %
5 Years 119.850+19.885
+239.09 %
Annualised Return Annualised --
+27.66 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 15.320 - 84.560 Change From 1 Year Low +63.010 % Change From 1 Year Low (%) +411.29
Change From 1 Year High -6.230 % Change From 1 Year High (%) -7.37
2 Years Range 15.320 - 88.470 Change From 2 Years Low +63.010 % Change From 2 Years Low (%) +411.29
Change From 2 Years High -10.140 % Change From 2 Years High (%) -11.46
5 Years Range 15.320 - 88.470 Change From 5 Years Low +63.010 % Change From 5 Years Low (%) +411.29
Change From 5 Years High -10.140 % Change From 5 Years High (%) -11.46
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Historical Price Data

Date Open High Low Close Volume VWAP
15 Oct 2021 78.200 79.060 77.980 78.330 12,864,280 -
14 Oct 2021 78.970 79.670 77.980 78.330 14,592,000 -
13 Oct 2021 79.590 79.660 78.780 78.950 9,459,177 -
12 Oct 2021 80.180 80.180 79.245 79.590 10,929,850 -
11 Oct 2021 81.635 81.635 79.870 79.930 11,251,300 -
08 Oct 2021 81.670 81.800 80.525 80.630 12,112,210 -
07 Oct 2021 81.540 82.670 81.030 81.940 14,183,350 -
06 Oct 2021 81.500 81.680 80.150 80.660 17,591,540 -
05 Oct 2021 82.780 83.390 81.300 81.600 28,958,200 -
04 Oct 2021 84.170 84.560 82.420 83.100 53,500,620 -
01 Oct 2021 81.560 84.340 80.630 81.400 102,264,700 -
30 Sep 2021 75.580 76.650 75.100 75.110 16,248,300 -
29 Sep 2021 73.610 75.700 73.575 75.090 16,049,610 -
28 Sep 2021 73.550 73.820 72.660 73.320 11,824,450 -
27 Sep 2021 73.510 74.266 73.340 73.360 8,625,154 -
24 Sep 2021 73.590 74.630 73.350 73.610 14,713,200 -
23 Sep 2021 72.680 74.040 72.570 73.050 12,807,050 -
22 Sep 2021 72.330 72.411 71.860 72.040 9,026,043 -
21 Sep 2021 72.480 72.680 71.770 71.970 11,994,760 -
20 Sep 2021 71.160 72.615 71.120 71.930 15,981,340 -
17 Sep 2021 71.190 72.000 70.890 71.680 43,406,260 -
16 Sep 2021 73.020 73.020 71.690 71.970 14,809,100 -
Summary
Current 2 Weeks
(04 Oct 2021 to 15 Oct 2021)
84.170 84.560 77.980 78.330 185,442,527 -
Previous 2 Weeks
(20 Sep 2021 to 01 Oct 2021)
71.160 84.560 71.120 81.400 219,534,607 -
4 Weeks from
(20 Aug 2021 to 17 Sep 2021)
78.530 84.560 77.980 71.680 226,896,122 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.